Author:
Patel Meghana,Nandpal Manish,Parekh Nikunj,Gunvantbhai Patel Samir,Patel Alkeshkumar
Publisher
Springer Nature Singapore
Reference59 articles.
1. AL-Sabbagh A, Olech E, McClellan JE, Kirchhoff CF (2016) Development of biosimilars. Semin Arthritis Rheum 45(5)
2. AMGEN Biosimilars (2024) The process and quality standards, AMGEN Biosimilars [Internet]. [cited 2024 Jan 9]. Developing BIOSIMILARS. https://www.amgenbiosimilars.com/
3. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343
4. Anonymous (2022) POST-ECBS version ENGLISH ONLY Guidelines on evaluation of biosimilars Replacement of Annex 2 of WHO Technical Report Series, No. 977
5. Anonymous (n.d.-a) Annex 2 guidelines on evaluation of monoclonal antibodies as similar biotherapeutic products (SBPs)